Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.39 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.37 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | SRC | P12931 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | GRM7 | Q14831 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7889952 | 0.84 | DPP4 (0.32) | DPP4F2TSHRTAAR1HTR2A | |
| SCHEMBL9140660 | 0.79 | CFTR (0.52) | CYP2D6 | |
| SCHEMBL28853373 | 0.77 | CHRNB2 (0.33) | — | |
| SCHEMBL3817688 | 0.76 | — | — | |
| SCHEMBL8386068 | 0.74 | DPP4 (0.41) | DPP4F2TSHRTAAR1HTR2A | |
| SCHEMBL4774509 | 0.73 | DPP4 (0.45) | DPP4F2TSHRTAAR1HTR2A | |
| SCHEMBL5420712 | 0.73 | MAPT (0.35) | DPP4F2TSHRTAAR1LMNA | |
| SCHEMBL1494253 | 0.71 | DPP4 (0.43) | DPP4F2TSHRTAAR1HTR2A | |
| SCHEMBL842216 | 0.71 | DPP4 (0.43) | DPP4F2TSHRTAAR1HTR2A | |
| SCHEMBL23532355 | 0.70 | DPP4 (0.33) | DPP4F2TSHRTAAR1HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9890231-B2 | Triarylphosphine or triarylarsine compound, alpha-olefin polymerization catalyst using the compound, ternary copolymer, and production process of alpha-olefin-((meth)acrylic acid)-based copolymer | JAPAN POLYETHYLENE CORPORATION (JP) | 2018-02-13 | — | — | US | disclosed |
| US-20160264699-A1 | NOVEL TRIARYLPHOSPHINE OR TRIARYLARSINE COMPOUND, ALPHA-OLEFIN POLYMERIZATION CATALYST USING THE COMPOUND, TERNARY COPOLYMER, AND PRODUCTION PROCESS OF ALPHA-OLEFIN -((METH)ACRYLIC ACID)-BASED COPOLYMER | JAPAN POLYETHYLENE CORPORATION (JP) | 2016-09-15 | — | — | US | disclosed |
| US-9376459-B2 | Triarylphosphine or triarylarsine compound, alpha-olefin polymerization catalyst using the compound, ternary copolymer, and production process of alpha-olefin-((meth)acrylic acid)-based copolymer | JAPAN POLYETHYLENE CORPORATION (JP) | 2016-06-28 | — | — | US | disclosed |
| US-20110257351-A1 | NOVEL TRIARYLPHOSPHINE OR TRIARYLARSINE COMPOUND, ALPHA-OLEFIN POLYMERIZATION CATALYST USING THE COMPOUND, TERNARY COPOLYMER, AND PRODUCTION PROCESS OF ALPHA-OLEFIN -((METH)ACRYLIC ACID)-BASED COPOLYMER | JAPAN POLYPROPYLENE CORPORATION (JP) | 2011-10-20 | — | — | US | disclosed |
| US-7659005-B2 | Label can be attached to product having high temperatures during high-temperature treatment or immediately after treatment; employs as sticking layer a hardened coating film including a silicone resin and a polymetallocarbosilane resin, zinc powder, tin powder, and aluminum powder | YUSHI-SEIHIN CO., LTD. (JP) | 2010-02-09 | — | — | US | disclosed |
| US-20070027241-A1 | Heat-resistant label applicable at high temperature | YUSHI-SEIHIN CO., LTD. (JP) | 2007-02-01 | — | — | US | disclosed |
| EP-1659162-A1 | HEAT-RESISTANT LABEL APPLICABLE AT HIGH TEMPERATURE | Yushi-Seihin Co., Ltd. (JP) | 2006-05-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110257351-A1 | NOVEL TRIARYLPHOSPHINE OR TRIARYLARSINE COMPOUND, ALPHA-OLEFIN POLYMERIZATION CATALYST USING THE COMPOUND, TERNARY COPOLYMER, AND PRODUCTION PROCESS OF ALPHA-OLEFIN -((METH)ACRYLIC ACID)-BASED COPOLYMER | AS3MT, ATR, ALK | DPP4 4844/4885F2 2445/4885TSHR 621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.